Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy

NCT ID: NCT05913245

Last Updated: 2023-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-30

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent years, the world of anesthesiology is questioning one of its great dogmas: Are so many hours of strict fasting necessary in patients who are candidates for elective surgeries? The main objective of our clinical trial will be demonstrate whether preoperative oral loading with hydrocarbonate beverages reduces the time of return of intestinal function in the postoperative period compared to water administration and strict fasting in patients undergoing elective radical cystectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many anaesthesiology societies now recommend intake of clear fluids (water, tea or coffee without milk, juices without pulp) up to two hours before induction of anaesthesia for most patients undergoing elective surgery. This change the traditional practice of overnight fasting, while reducing thirst in the hours before surgery and seems to attenuate the response to the stress that results from a major operation, such as activation of endocrine and inflammatory systems which leads to tissue catabolism and insulin resistance. Among all the complications, one of the most frequent in patients undergoing mayor surgeries is undoubtedly paralytic ileus. The Enhanced Recovery After Surgery (ERAS) guidelines emphasize the importance of preventing this event. To prevent ileus, prokinetic agents such as metoclopramide are used, which although it has not been shown to shorten the period until the first flatulence or the first peristaltic movement, decrease nausea and vomiting. Chewing gum is another measure that is carried out, since it stimulates peristalsis and this measure if it had significant effects in time until first flatulence and in time until first peristaltic movement. In recent years there has been a great change in the perioperative management of patients who will undergo a radical cystectomy. The weight of traditional perioperative care has been an important barrier to the implementation of Fast Track (FT) protocols, since it is difficult to change a therapeutic strategy that has been carried out for decades. The positive results obtained in colorectal surgery led to Fast Track being implemented in other types of surgery similar to colorectal surgery such as radical cystectomy. Although there is apparently widespread enthusiasm for the implementation of Fast Track protocols, evidence of the use of this type of protocols in cystectomy is not robust, numerous studies claim that there is a big difference between the application of FT and the application of traditional measures in terms of length of hospital stay or complications. Because of this, more large-volume randomized experimental studies of patients are needed. This randomized double blind placebo-controlled trial of preoperative oral carbohydrate (CHO) treatment in patients undergoing elective radical cystectomy will investigate whether this treatment reduced the time of return of intestinal function. Secondary outcomes will be the incidence of infection of surgical wounds, the incidence of postoperative complications, the length of hospital stay and early postoperative fatigue in the three groups of patients undergoing this type of surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Urologic Cancer Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fasting arm

Patients included in the fasting arm will not drink or eat anything after the dinner of the night before the surgery.

Group Type NO_INTERVENTION

No interventions assigned to this group

Water arm

Patients included in the water intake arm will drink the same amount of mililiters than the carbohydrate loading drink.

Group Type ACTIVE_COMPARATOR

Water

Intervention Type OTHER

Preoperative water

Carbohydrate loading arm

Patients included in the intake arm of carbohydrate loading treatment should take 400ml the night before the intervention and 200ml the two hours before the intervention.

The hydrocarbonate drink provided will be Sugarmix (Maltodextrin 12.5%).

Group Type EXPERIMENTAL

Maltodextrin 12.5%

Intervention Type DIETARY_SUPPLEMENT

Preoperative Maltodextrin 12.5%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maltodextrin 12.5%

Preoperative Maltodextrin 12.5%

Intervention Type DIETARY_SUPPLEMENT

Water

Preoperative water

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent.
* Patients older than 18 years old proposed for radical cystectomy.

Exclusion Criteria

* American Society of Anesthesiologists (ASA) classification grade: IV
* Renal failure (creatinine levels above 3 mg/dL or dialysis)
* Liver failure (Child-Pugh B or higher)
* Gastroesophageal reflux disease.
* Gastrointestinal obstruction.
* Ongoing treatment with corticosteroids.
* Previous infections within the last 3 months.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel López-Herrera Rodriguez

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clara Rosso, PhD

Role: STUDY_CHAIR

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fundación Pública Andaluza para la Gestión de Investigación de Salud en Sevilla

Seville, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel López-Herrera Rodríguez, PhD

Role: CONTACT

0034-955012276

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1738-N-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transverse Abdominus Plane Block Study
NCT05216055 WITHDRAWN PHASE2
Perioperative Protective Effects of Lidocaine
NCT00413127 TERMINATED PHASE2/PHASE3